Ashish Vyas
Overview
Explore the profile of Ashish Vyas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chaudhary S, Kaur P, Singh T, Bano K, Vyas A, Mishra A, et al.
Biogerontology
. 2024 Oct;
26(1):1.
PMID: 39441393
The early-life gut microbiota (GM) is increasingly recognized for its contributions to human health and disease over time. Microbiota composition, influenced by factors like race, geography, lifestyle, and individual differences,...
2.
Duppala S, Poleboyina P, Kour B, Bale G, Vyas A, Pawar S, et al.
Indian J Microbiol
. 2024 Sep;
64(3):1222-1245.
PMID: 39282199
Cervical malignancy (CC) is the 2nd most prevalent malignancy among females, leading to cancer mortality. Primary detection of CC tumors results in an improved prognosis. CC is a malignant gynecological...
3.
Singh N, Mahant V, Bhasin R, Verma K, Kumar A, Vyas A
Indian J Microbiol
. 2024 Sep;
64(3):1339-1346.
PMID: 39282187
Antimicrobial Resistance (AMR) due to non-responding viruses, fungi, bacteria and parasites leads to discovery of new antimicrobial medicines which can control the risk of disease spread, severe illness, disability and...
4.
Gaur V, Kumar N, Vyas A, Chowdhury D, Singh J, Bera S
J Biomol Struct Dyn
. 2023 Dec;
43(7):3286-3296.
PMID: 38149858
Indiscriminate use of anti-microbial agents has resulted in the inception, frequency, and spread of antibiotic resistance among targeted bacterial pathogens and the commensal flora. Mur enzymes, playing a crucial role...
5.
Dravid P, Murthy S, Attia Z, Cassady C, Chandra R, Trivedi S, et al.
PLoS Pathog
. 2023 Oct;
19(10):e1011697.
PMID: 37812637
Immune correlates of hepatitis C virus (HCV) clearance and control remain poorly defined due to the lack of an informative animal model. We recently described acute and chronic rodent HCV-like...
6.
Garg S, Dubey R, Sharma S, Vyas A, Gupta J
Int J Biol Macromol
. 2023 Jul;
247:125636.
PMID: 37392924
A chronic wound is a serious complication associated with diabetes mellitus and is difficult to heal due to high glucose levels, oxidative stress, and biofilm-associated microbial infection. The structural complexity...
7.
Anjum S, Vyas A, Sofi T
J Sci Food Agric
. 2023 Feb;
103(10):4727-4741.
PMID: 36781932
In the field of nanotechnology, the use of biologically active products from fungi for the reduction and synthesis of nanoparticles as an alternative to toxic chemicals has received extensive attention,...
8.
Shidiki A, Vyas A
BioTechnologia (Pozn)
. 2023 Jan;
103(1):5-18.
PMID: 36605380
Background: MRSA and MLSB resistant are known as important pathogens, which are responsible for many cases of both hospital and community-acquired infections worldwide. Studying drug discovery from plant sources is...
9.
Kaur T, Bala M, Kumar G, Vyas A
Arch Microbiol
. 2022 Sep;
204(10):620.
PMID: 36100763
The biogenic method for synthesis of nanoparticles is preferred over the traditional strategies, on account of its ease, environmental friendliness, and cost-effectivity, wherein fungi endorse themselves to be the most...
10.
Mehta K, Sharma P, Mujawar S, Vyas A
Int J Pept Res Ther
. 2022 Jul;
28(5):132.
PMID: 35891800
Tuberculosis (TB) is one of the leading cause of death worldwide, and the world is fighting with this global health emergency from the past 25 year. The current clinical interventions...